Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123.
Clinical trial NCT02106338 · COMPLETED
Trial details
- NCT number
- NCT02106338
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2014-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.